Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study
Annals of the Rheumatic Diseases · 2025
DOI: 10.1016/j.ard.2025.01.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Emily Rayens und 17 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Southern California, Pasadena, CA, USA. Electronic address: emily.x.rayens@kp.org. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Herpes Zoster, Herpes Zoster Vaccine, Neuralgia, Postherpetic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kaiser Permanente Southern California, GlaxoSmithKline.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kaiser Permanente Southern California, Pasadena, CA, USA. Electronic address: emily.x.rayens@kp.org.
- Kaiser Permanente Southern California, Pasadena, CA, USA.
- GSK, Rockville, MD, USA.
- Kaiser Permanente Southern California, Pasadena, CA, USA; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
Förderung
- Kaiser Permanente Southern California
- GlaxoSmithKline
Zitieren
APA
Rayens, E., Sy, L. S., Qian, L., Wu, J., Ackerson, B. K., Luo, Y., Cheng, Y., Lin, A. T., Solano, Z., De Jesus, J., Amundsen, B., Florea, A., Ku, J. H., Chmielewski-Yee, E., Oraichi, D., Seifert, H., Yun, H., & Tseng, H. F. (2025). Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.01.045
Vancouver
Rayens E, Sy LS, Qian L, Wu J, Ackerson BK, Luo Y, et al. Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.01.045
BibTeX
@article{Rayens2025,
author = {Rayens, Emily and Sy, Lina S and Qian, Lei and Wu, Jun and Ackerson, Bradley K and Luo, Yi and Cheng, Yanjun and Lin, Antony T and Solano, Zendi and De Jesus, Justine and Amundsen, Britta and Florea, Ana and Ku, Jennifer H and Chmielewski-Yee, Elizabeth and Oraichi, Driss and Seifert, Harry and Yun, Huifeng and Tseng, Hung Fu},
title = {Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
doi = {10.1016/j.ard.2025.01.045}
}
EUVIMED